Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by NGS Based Diagnostics Revenue 1.4 Market Analysis by Type 1.4.1 Global NGS Based Diagnostics Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 DNA Sequencing 1.4.3 RNA Sequencing 1.4.4 Whole Genome Sequencing 1.4.5 Whole Exome Sequencing 1.4.6 Other 1.5 Market by Application 1.5.1 Global NGS Based Diagnostics Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Clinics 1.5.4 Academics/Research Institutions 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 NGS Based Diagnostics Market Perspective (2015-2026) 2.2 NGS Based Diagnostics Growth Trends by Regions 2.2.1 NGS Based Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 NGS Based Diagnostics Historic Market Share by Regions (2015-2020) 2.2.3 NGS Based Diagnostics Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 NGS Based Diagnostics Market Growth Strategy 2.3.6 Primary Interviews with Key NGS Based Diagnostics Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top NGS Based Diagnostics Players by Market Size 3.1.1 Global Top NGS Based Diagnostics Players by Revenue (2015-2020) 3.1.2 Global NGS Based Diagnostics Revenue Market Share by Players (2015-2020) 3.1.3 Global NGS Based Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global NGS Based Diagnostics Market Concentration Ratio 3.2.1 Global NGS Based Diagnostics Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by NGS Based Diagnostics Revenue in 2019 3.3 NGS Based Diagnostics Key Players Head office and Area Served 3.4 Key Players NGS Based Diagnostics Product Solution and Service 3.5 Date of Enter into NGS Based Diagnostics Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global NGS Based Diagnostics Historic Market Size by Type (2015-2020) 4.2 Global NGS Based Diagnostics Forecasted Market Size by Type (2021-2026) 5 NGS Based Diagnostics Breakdown Data by Application (2015-2026) 5.1 Global NGS Based Diagnostics Market Size by Application (2015-2020) 5.2 Global NGS Based Diagnostics Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America NGS Based Diagnostics Market Size (2015-2020) 6.2 NGS Based Diagnostics Key Players in North America (2019-2020) 6.3 North America NGS Based Diagnostics Market Size by Type (2015-2020) 6.4 North America NGS Based Diagnostics Market Size by Application (2015-2020) 7 Europe 7.1 Europe NGS Based Diagnostics Market Size (2015-2020) 7.2 NGS Based Diagnostics Key Players in Europe (2019-2020) 7.3 Europe NGS Based Diagnostics Market Size by Type (2015-2020) 7.4 Europe NGS Based Diagnostics Market Size by Application (2015-2020) 8 China 8.1 China NGS Based Diagnostics Market Size (2015-2020) 8.2 NGS Based Diagnostics Key Players in China (2019-2020) 8.3 China NGS Based Diagnostics Market Size by Type (2015-2020) 8.4 China NGS Based Diagnostics Market Size by Application (2015-2020) 9 Japan 9.1 Japan NGS Based Diagnostics Market Size (2015-2020) 9.2 NGS Based Diagnostics Key Players in Japan (2019-2020) 9.3 Japan NGS Based Diagnostics Market Size by Type (2015-2020) 9.4 Japan NGS Based Diagnostics Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia NGS Based Diagnostics Market Size (2015-2020) 10.2 NGS Based Diagnostics Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia NGS Based Diagnostics Market Size by Type (2015-2020) 10.4 Southeast Asia NGS Based Diagnostics Market Size by Application (2015-2020) 11 India 11.1 India NGS Based Diagnostics Market Size (2015-2020) 11.2 NGS Based Diagnostics Key Players in India (2019-2020) 11.3 India NGS Based Diagnostics Market Size by Type (2015-2020) 11.4 India NGS Based Diagnostics Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America NGS Based Diagnostics Market Size (2015-2020) 12.2 NGS Based Diagnostics Key Players in Central & South America (2019-2020) 12.3 Central & South America NGS Based Diagnostics Market Size by Type (2015-2020) 12.4 Central & South America NGS Based Diagnostics Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Janssen 13.1.1 Janssen Company Details 13.1.2 Janssen Business Overview and Its Total Revenue 13.1.3 Janssen NGS Based Diagnostics Introduction 13.1.4 Janssen Revenue in NGS Based Diagnostics Business (2015-2020)) 13.1.5 Janssen Recent Development 13.2 Roche 13.2.1 Roche Company Details 13.2.2 Roche Business Overview and Its Total Revenue 13.2.3 Roche NGS Based Diagnostics Introduction 13.2.4 Roche Revenue in NGS Based Diagnostics Business (2015-2020) 13.2.5 Roche Recent Development 13.3 Qiagen 13.3.1 Qiagen Company Details 13.3.2 Qiagen Business Overview and Its Total Revenue 13.3.3 Qiagen NGS Based Diagnostics Introduction 13.3.4 Qiagen Revenue in NGS Based Diagnostics Business (2015-2020) 13.3.5 Qiagen Recent Development 13.4 ThermoFisher Scientific 13.4.1 ThermoFisher Scientific Company Details 13.4.2 ThermoFisher Scientific Business Overview and Its Total Revenue 13.4.3 ThermoFisher Scientific NGS Based Diagnostics Introduction 13.4.4 ThermoFisher Scientific Revenue in NGS Based Diagnostics Business (2015-2020) 13.4.5 ThermoFisher Scientific Recent Development 13.5 Oxford Gene Technology 13.5.1 Oxford Gene Technology Company Details 13.5.2 Oxford Gene Technology Business Overview and Its Total Revenue 13.5.3 Oxford Gene Technology NGS Based Diagnostics Introduction 13.5.4 Oxford Gene Technology Revenue in NGS Based Diagnostics Business (2015-2020) 13.5.5 Oxford Gene Technology Recent Development 13.6 Illumina 13.6.1 Illumina Company Details 13.6.2 Illumina Business Overview and Its Total Revenue 13.6.3 Illumina NGS Based Diagnostics Introduction 13.6.4 Illumina Revenue in NGS Based Diagnostics Business (2015-2020) 13.6.5 Illumina Recent Development 13.7 Pacific Biosciences 13.7.1 Pacific Biosciences Company Details 13.7.2 Pacific Biosciences Business Overview and Its Total Revenue 13.7.3 Pacific Biosciences NGS Based Diagnostics Introduction 13.7.4 Pacific Biosciences Revenue in NGS Based Diagnostics Business (2015-2020) 13.7.5 Pacific Biosciences Recent Development 13.8 Paradigm Diagnostics 13.8.1 Paradigm Diagnostics Company Details 13.8.2 Paradigm Diagnostics Business Overview and Its Total Revenue 13.8.3 Paradigm Diagnostics NGS Based Diagnostics Introduction 13.8.4 Paradigm Diagnostics Revenue in NGS Based Diagnostics Business (2015-2020) 13.8.5 Paradigm Diagnostics Recent Development 13.9 Innogene Kalbiotech 13.9.1 Innogene Kalbiotech Company Details 13.9.2 Innogene Kalbiotech Business Overview and Its Total Revenue 13.9.3 Innogene Kalbiotech NGS Based Diagnostics Introduction 13.9.4 Innogene Kalbiotech Revenue in NGS Based Diagnostics Business (2015-2020) 13.9.5 Innogene Kalbiotech Recent Development 13.10 Admera Health 13.10.1 Admera Health Company Details 13.10.2 Admera Health Business Overview and Its Total Revenue 13.10.3 Admera Health NGS Based Diagnostics Introduction 13.10.4 Admera Health Revenue in NGS Based Diagnostics Business (2015-2020) 13.10.5 Admera Health Recent Development 13.11 AITbiotech 10.11.1 AITbiotech Company Details 10.11.2 AITbiotech Business Overview and Its Total Revenue 10.11.3 AITbiotech NGS Based Diagnostics Introduction 10.11.4 AITbiotech Revenue in NGS Based Diagnostics Business (2015-2020) 10.11.5 AITbiotech Recent Development 13.12 Centogene 10.12.1 Centogene Company Details 10.12.2 Centogene Business Overview and Its Total Revenue 10.12.3 Centogene NGS Based Diagnostics Introduction 10.12.4 Centogene Revenue in NGS Based Diagnostics Business (2015-2020) 10.12.5 Centogene Recent Development 13.13 Phalanx Biotech Group 10.13.1 Phalanx Biotech Group Company Details 10.13.2 Phalanx Biotech Group Business Overview and Its Total Revenue 10.13.3 Phalanx Biotech Group NGS Based Diagnostics Introduction 10.13.4 Phalanx Biotech Group Revenue in NGS Based Diagnostics Business (2015-2020) 10.13.5 Phalanx Biotech Group Recent Development 13.14 iGenomX 10.14.1 iGenomX Company Details 10.14.2 iGenomX Business Overview and Its Total Revenue 10.14.3 iGenomX NGS Based Diagnostics Introduction 10.14.4 iGenomX Revenue in NGS Based Diagnostics Business (2015-2020) 10.14.5 iGenomX Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. NGS Based Diagnostics Key Market Segments Table 2. Key Players Covered: Ranking by NGS Based Diagnostics Revenue Table 3. Ranking of Global Top NGS Based Diagnostics Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global NGS Based Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of DNA Sequencing Table 6. Key Players of RNA Sequencing Table 7. Key Players of Whole Genome Sequencing Table 8. Key Players of Whole Exome Sequencing Table 9. Key Players of Other Table 10. Global NGS Based Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 11. Global NGS Based Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026 Table 12. Global NGS Based Diagnostics Market Size by Regions (2015-2020) (US$ Million) Table 13. Global NGS Based Diagnostics Market Share by Regions (2015-2020) Table 14. Global NGS Based Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 15. Global NGS Based Diagnostics Market Share by Regions (2021-2026) Table 16. Market Top Trends Table 17. Key Drivers: Impact Analysis Table 18. Key Challenges Table 19. NGS Based Diagnostics Market Growth Strategy Table 20. Main Points Interviewed from Key NGS Based Diagnostics Players Table 21. Global NGS Based Diagnostics Revenue by Players (2015-2020) (Million US$) Table 22. Global NGS Based Diagnostics Market Share by Players (2015-2020) Table 23. Global Top NGS Based Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NGS Based Diagnostics as of 2019) Table 24. Global NGS Based Diagnostics by Players Market Concentration Ratio (CR5 and HHI) Table 25. Key Players Headquarters and Area Served Table 26. Key Players NGS Based Diagnostics Product Solution and Service Table 27. Date of Enter into NGS Based Diagnostics Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global NGS Based Diagnostics Market Size by Type (2015-2020) (Million US$) Table 30. Global NGS Based Diagnostics Market Size Share by Type (2015-2020) Table 31. Global NGS Based Diagnostics Revenue Market Share by Type (2021-2026) Table 32. Global NGS Based Diagnostics Market Size Share by Application (2015-2020) Table 33. Global NGS Based Diagnostics Market Size by Application (2015-2020) (Million US$) Table 34. Global NGS Based Diagnostics Market Size Share by Application (2021-2026) Table 35. North America Key Players NGS Based Diagnostics Revenue (2019-2020) (Million US$) Table 36. North America Key Players NGS Based Diagnostics Market Share (2019-2020) Table 37. North America NGS Based Diagnostics Market Size by Type (2015-2020) (Million US$) Table 38. North America NGS Based Diagnostics Market Share by Type (2015-2020) Table 39. North America NGS Based Diagnostics Market Size by Application (2015-2020) (Million US$) Table 40. North America NGS Based Diagnostics Market Share by Application (2015-2020) Table 41. Europe Key Players NGS Based Diagnostics Revenue (2019-2020) (Million US$) Table 42. Europe Key Players NGS Based Diagnostics Market Share (2019-2020) Table 43. Europe NGS Based Diagnostics Market Size by Type (2015-2020) (Million US$) Table 44. Europe NGS Based Diagnostics Market Share by Type (2015-2020) Table 45. Europe NGS Based Diagnostics Market Size by Application (2015-2020) (Million US$) Table 46. Europe NGS Based Diagnostics Market Share by Application (2015-2020) Table 47. China Key Players NGS Based Diagnostics Revenue (2019-2020) (Million US$) Table 48. China Key Players NGS Based Diagnostics Market Share (2019-2020) Table 49. China NGS Based Diagnostics Market Size by Type (2015-2020) (Million US$) Table 50. China NGS Based Diagnostics Market Share by Type (2015-2020) Table 51. China NGS Based Diagnostics Market Size by Application (2015-2020) (Million US$) Table 52. China NGS Based Diagnostics Market Share by Application (2015-2020) Table 53. Japan Key Players NGS Based Diagnostics Revenue (2019-2020) (Million US$) Table 54. Japan Key Players NGS Based Diagnostics Market Share (2019-2020) Table 55. Japan NGS Based Diagnostics Market Size by Type (2015-2020) (Million US$) Table 56. Japan NGS Based Diagnostics Market Share by Type (2015-2020) Table 57. Japan NGS Based Diagnostics Market Size by Application (2015-2020) (Million US$) Table 58. Japan NGS Based Diagnostics Market Share by Application (2015-2020) Table 59. Southeast Asia Key Players NGS Based Diagnostics Revenue (2019-2020) (Million US$) Table 60. Southeast Asia Key Players NGS Based Diagnostics Market Share (2019-2020) Table 61. Southeast Asia NGS Based Diagnostics Market Size by Type (2015-2020) (Million US$) Table 62. Southeast Asia NGS Based Diagnostics Market Share by Type (2015-2020) Table 63. Southeast Asia NGS Based Diagnostics Market Size by Application (2015-2020) (Million US$) Table 64. Southeast Asia NGS Based Diagnostics Market Share by Application (2015-2020) Table 65. India Key Players NGS Based Diagnostics Revenue (2019-2020) (Million US$) Table 66. India Key Players NGS Based Diagnostics Market Share (2019-2020) Table 67. India NGS Based Diagnostics Market Size by Type (2015-2020) (Million US$) Table 68. India NGS Based Diagnostics Market Share by Type (2015-2020) Table 69. India NGS Based Diagnostics Market Size by Application (2015-2020) (Million US$) Table 70. India NGS Based Diagnostics Market Share by Application (2015-2020) Table 71. Central & South America Key Players NGS Based Diagnostics Revenue (2019-2020) (Million US$) Table 72. Central & South America Key Players NGS Based Diagnostics Market Share (2019-2020) Table 73. Central & South America NGS Based Diagnostics Market Size by Type (2015-2020) (Million US$) Table 74. Central & South America NGS Based Diagnostics Market Share by Type (2015-2020) Table 75. Central & South America NGS Based Diagnostics Market Size by Application (2015-2020) (Million US$) Table 76. Central & South America NGS Based Diagnostics Market Share by Application (2015-2020) Table 77. Janssen Company Details Table 78. Janssen Business Overview Table 79. Janssen Product Table 80. Janssen Revenue in NGS Based Diagnostics Business (2015-2020) (Million US$) Table 81. Janssen Recent Development Table 82. Roche Company Details Table 83. Roche Business Overview Table 84. Roche Product Table 85. Roche Revenue in NGS Based Diagnostics Business (2015-2020) (Million US$) Table 86. Roche Recent Development Table 87. Qiagen Company Details Table 88. Qiagen Business Overview Table 89. Qiagen Product Table 90. Qiagen Revenue in NGS Based Diagnostics Business (2015-2020) (Million US$) Table 91. Qiagen Recent Development Table 92. ThermoFisher Scientific Company Details Table 93. ThermoFisher Scientific Business Overview Table 94. ThermoFisher Scientific Product Table 95. ThermoFisher Scientific Revenue in NGS Based Diagnostics Business (2015-2020) (Million US$) Table 96. ThermoFisher Scientific Recent Development Table 97. Oxford Gene Technology Company Details Table 98. Oxford Gene Technology Business Overview Table 99. Oxford Gene Technology Product Table 100. Oxford Gene Technology Revenue in NGS Based Diagnostics Business (2015-2020) (Million US$) Table 101. Oxford Gene Technology Recent Development Table 102. Illumina Company Details Table 103. Illumina Business Overview Table 104. Illumina Product Table 105. Illumina Revenue in NGS Based Diagnostics Business (2015-2020) (Million US$) Table 106. Illumina Recent Development Table 107. Pacific Biosciences Company Details Table 108. Pacific Biosciences Business Overview Table 109. Pacific Biosciences Product Table 110. Pacific Biosciences Revenue in NGS Based Diagnostics Business (2015-2020) (Million US$) Table 111. Pacific Biosciences Recent Development Table 112. Paradigm Diagnostics Business Overview Table 113. Paradigm Diagnostics Product Table 114. Paradigm Diagnostics Company Details Table 115. Paradigm Diagnostics Revenue in NGS Based Diagnostics Business (2015-2020) (Million US$) Table 116. Paradigm Diagnostics Recent Development Table 117. Innogene Kalbiotech Company Details Table 118. Innogene Kalbiotech Business Overview Table 119. Innogene Kalbiotech Product Table 120. Innogene Kalbiotech Revenue in NGS Based Diagnostics Business (2015-2020) (Million US$) Table 121. Innogene Kalbiotech Recent Development Table 122. Admera Health Company Details Table 123. Admera Health Business Overview Table 124. Admera Health Product Table 125. Admera Health Revenue in NGS Based Diagnostics Business (2015-2020) (Million US$) Table 126. Admera Health Recent Development Table 127. AITbiotech Company Details Table 128. AITbiotech Business Overview Table 129. AITbiotech Product Table 130. AITbiotech Revenue in NGS Based Diagnostics Business (2015-2020) (Million US$) Table 131. AITbiotech Recent Development Table 132. Centogene Company Details Table 133. Centogene Business Overview Table 134. Centogene Product Table 135. Centogene Revenue in NGS Based Diagnostics Business (2015-2020) (Million US$) Table 136. Centogene Recent Development Table 137. Phalanx Biotech Group Company Details Table 138. Phalanx Biotech Group Business Overview Table 139. Phalanx Biotech Group Product Table 140. Phalanx Biotech Group Revenue in NGS Based Diagnostics Business (2015-2020) (Million US$) Table 141. Phalanx Biotech Group Recent Development Table 142. iGenomX Company Details Table 143. iGenomX Business Overview Table 144. iGenomX Product Table 145. iGenomX Revenue in NGS Based Diagnostics Business (2015-2020) (Million US$) Table 146. iGenomX Recent Development Table 147. Research Programs/Design for This Report Table 148. Key Data Information from Secondary Sources Table 149. Key Data Information from Primary Sources List of Figures Figure 1. Global NGS Based Diagnostics Market Share by Type: 2020 VS 2026 Figure 2. DNA Sequencing Features Figure 3. RNA Sequencing Features Figure 4. Whole Genome Sequencing Features Figure 5. Whole Exome Sequencing Features Figure 6. Other Features Figure 7. Global NGS Based Diagnostics Market Share by Application: 2020 VS 2026 Figure 8. Hospitals Case Studies Figure 9. Clinics Case Studies Figure 10. Academics/Research Institutions Case Studies Figure 11. NGS Based Diagnostics Report Years Considered Figure 12. Global NGS Based Diagnostics Market Size YoY Growth 2015-2026 (US$ Million) Figure 13. Global NGS Based Diagnostics Market Share by Regions: 2020 VS 2026 Figure 14. Global NGS Based Diagnostics Market Share by Regions (2021-2026) Figure 15. Porter's Five Forces Analysis Figure 16. Global NGS Based Diagnostics Market Share by Players in 2019 Figure 17. Global Top NGS Based Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NGS Based Diagnostics as of 2019 Figure 18. The Top 10 and 5 Players Market Share by NGS Based Diagnostics Revenue in 2019 Figure 19. North America NGS Based Diagnostics Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Europe NGS Based Diagnostics Market Size YoY Growth (2015-2020) (Million US$) Figure 21. China NGS Based Diagnostics Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Japan NGS Based Diagnostics Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Southeast Asia NGS Based Diagnostics Market Size YoY Growth (2015-2020) (Million US$) Figure 24. India NGS Based Diagnostics Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Central & South America NGS Based Diagnostics Market Size YoY Growth (2015-2020) (Million US$) Figure 26. Janssen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Janssen Revenue Growth Rate in NGS Based Diagnostics Business (2015-2020) Figure 28. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Roche Revenue Growth Rate in NGS Based Diagnostics Business (2015-2020) Figure 30. Qiagen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Qiagen Revenue Growth Rate in NGS Based Diagnostics Business (2015-2020) Figure 32. ThermoFisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. ThermoFisher Scientific Revenue Growth Rate in NGS Based Diagnostics Business (2015-2020) Figure 34. Oxford Gene Technology Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Oxford Gene Technology Revenue Growth Rate in NGS Based Diagnostics Business (2015-2020) Figure 36. Illumina Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Illumina Revenue Growth Rate in NGS Based Diagnostics Business (2015-2020) Figure 38. Pacific Biosciences Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. Pacific Biosciences Revenue Growth Rate in NGS Based Diagnostics Business (2015-2020) Figure 40. Paradigm Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. Paradigm Diagnostics Revenue Growth Rate in NGS Based Diagnostics Business (2015-2020) Figure 42. Innogene Kalbiotech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 43. Innogene Kalbiotech Revenue Growth Rate in NGS Based Diagnostics Business (2015-2020) Figure 44. Admera Health Total Revenue (US$ Million): 2019 Compared with 2018 Figure 45. Admera Health Revenue Growth Rate in NGS Based Diagnostics Business (2015-2020) Figure 46. AITbiotech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 47. AITbiotech Revenue Growth Rate in NGS Based Diagnostics Business (2015-2020) Figure 48. Centogene Total Revenue (US$ Million): 2019 Compared with 2018 Figure 49. Centogene Revenue Growth Rate in NGS Based Diagnostics Business (2015-2020) Figure 50. Phalanx Biotech Group Total Revenue (US$ Million): 2019 Compared with 2018 Figure 51. Phalanx Biotech Group Revenue Growth Rate in NGS Based Diagnostics Business (2015-2020) Figure 52. iGenomX Total Revenue (US$ Million): 2019 Compared with 2018 Figure 53. iGenomX Revenue Growth Rate in NGS Based Diagnostics Business (2015-2020) Figure 54. Bottom-up and Top-down Approaches for This Report Figure 55. Data Triangulation Figure 56. Key Executives Interviewed

Janssen Roche Qiagen ThermoFisher Scientific Oxford Gene Technology Illumina Pacific Biosciences Paradigm Diagnostics Innogene Kalbiotech Admera Health AITbiotech Centogene Phalanx Biotech Group iGenomX